- ISIN
- US35804M1053
- Sector
- Healthcare
- Industry
- Medical Care Facilities
Highlights
- Market Cap
- $116.07B
- Enterprise Value
- $130.17B
- EPS (TTM)
- €0.16
- PE Ratio
- 68.25
- PEG Ratio
- 4.86
- Total Revenue (TTM)
- €23.07B
- Gross Profit (TTM)
- €5.82B
- EBITDA (TTM)
- €3.35B
- Year Range
- $10.33 - $33.93
- Target Price
- $9.30
- ROA (TTM)
- 3.47%
- ROE (TTM)
- 7.44%
- Avg. Volume (1M)
- 320K
- Avg. Volume Value (1M)
- $3.93M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
FSNUY Performance Chart
Fresenius SE & Co KGaA ADR (FSNUY) is down 7.6% since the beginning of the year. At $13 per share, FSNUY is trading 62.0% below its 52-week high of $34. Investors who bought $1,000 worth of FSNUY shares 5 years ago would now be looking at an investment worth $1,075.
Loading charts...
Compare this symbol against anything
Returns By Period
Fresenius SE & Co KGaA ADR (FSNUY) has returned -7.63% so far this year and 10.49% over the past 12 months. Over the last ten years, FSNUY has returned -2.01% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Fresenius SE & Co KGaA ADR
- 1D
- -0.85%
- 1M
- 6.45%
- 6M
- -5.38%
- YTD
- -7.63%
- 1Y
- 10.49%
- 3Y*
- 20.01%
- 5Y*
- 1.45%
- 10Y*
- -2.01%
- ALL TIME*
- 4.97%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
FSNUY Monthly Returns History
Based on dividend-adjusted daily data since Dec 12, 2011, FSNUY's average daily return is +0.04%, while the average monthly return is +0.84%. At this rate, an investment would double in approximately 6.9 years.
Historically, 55% of months were positive and 45% were negative. The best month was Oct 2025 with a return of +59.8%, while the worst month was Nov 2025 at -38.8%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, FSNUY closed higher 49% of trading days. The best single day was Mar 24, 2020 with a return of +14.2%, while the worst single day was Dec 7, 2018 at -18.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.37% | 7.93% | -14.77% | -4.90% | -10.66% | 7.42% | 12.69% | -7.63% | |||||
| 2025 | 9.71% | 4.17% | 7.90% | 10.38% | 5.77% | 1.54% | -4.40% | 14.19% | 2.88% | 59.79% | -38.84% | 4.37% | 67.46% |
| 2024 | -9.51% | -0.43% | -2.73% | 11.52% | 5.36% | -5.46% | 20.11% | 2.96% | 3.01% | -4.28% | -3.49% | -1.13% | 13.27% |
| 2023 | 2.79% | -5.08% | -1.91% | 7.03% | -0.91% | 1.24% | 12.48% | 2.80% | -2.74% | -18.31% | 24.61% | -2.83% | 14.30% |
| 2022 | 5.41% | -17.40% | 7.02% | -4.68% | -0.68% | -12.25% | -14.23% | -3.26% | -13.94% | 5.96% | 21.62% | 1.01% | -28.04% |
| 2021 | -4.38% | -4.40% | 4.98% | 11.00% | 11.83% | -4.16% | 1.90% | -2.54% | -8.28% | -4.26% | -17.64% | 5.83% | -13.22% |
Benchmark Metrics
Fresenius SE & Co KGaA ADR has an annualized alpha of -0.40%, beta of 0.69, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since December 12, 2011.
- This stock participated in 100.29% of S&P 500 Index downside but only 67.56% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.69 may look defensive, but with R2 of 0.16 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.40%
- Beta
- 0.69
- R²
- 0.16
- Upside Capture
- 67.56%
- Downside Capture
- 100.29%
Return for Risk
Risk / Return Rank
FSNUY ranks 51 for risk / return — above 51% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Fresenius SE & Co KGaA ADR (FSNUY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FSNUY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -1.34 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.25 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.20 | 2.00 | -1.80 |
| Martin ratioReturn relative to average drawdown | 0.30 | 8.49 | -8.19 |
Dividends
Dividend History
Fresenius SE & Co KGaA ADR provided a 2.38% dividend yield over the last twelve months, with an annual payout of $0.31 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.31 | $0.28 | $0.00 | $0.25 | $0.24 | $0.18 | $0.24 | $0.15 | $0.15 | $0.11 | $0.10 | $0.08 |
Dividend yield | 2.38% | 1.92% | 0.00% | 3.20% | 3.44% | 1.82% | 2.04% | 1.08% | 1.27% | 0.58% | 0.51% | 0.45% |
Monthly Dividends
The table displays the monthly dividend distributions for Fresenius SE & Co KGaA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | |||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.24 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.18 |
Dividend Yield & Payout
Dividend Yield
Fresenius SE & Co KGaA ADR has a dividend yield of 2.38%, which is quite average when compared to the overall market.
Payout Ratio
Fresenius SE & Co KGaA ADR has a payout ratio of 47.42%, which is quite average when compared to the overall market. This suggests that Fresenius SE & Co KGaA ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Fresenius SE & Co KGaA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fresenius SE & Co KGaA ADR was 76.49%, occurring on Oct 12, 2022. Recovery took 765 trading sessions.
The current Fresenius SE & Co KGaA ADR drawdown is 41.04%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-76.49%Oct 2022 | 5y 3mo | 3y 19d | 8y 4moJun 2017 - Oct 2025 | Bear market2022 |
-52.39%Jun 2026 | 7mo | — | 9mo 2dNov 2025 - now | — |
-19.81%Feb 2016 | 3mo 8d | 2mo 10d | 5mo 18dNov 2015 - Apr 2016 | — |
-15.27%Nov 2016 | 1mo 28d | 5mo 2d | 7moSep 2016 - Apr 2017 | — |
-14.82%Jun 2012 | 2mo 27d | 1mo 2d | 3mo 29dMar 2012 - Jul 2012 | — |
Drawdown Indicators
| FSNUY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.49% | -56.78% | -19.71% |
Max Drawdown (1Y)Largest decline over 1 year | -52.39% | -9.10% | -43.29% |
Max Drawdown (3Y)Largest decline over 3 years | -52.39% | -18.90% | -33.49% |
Max Drawdown (5Y)Largest decline over 5 years | -64.24% | -25.43% | -38.81% |
Max Drawdown (10Y)Largest decline over 10 years | -76.49% | -33.92% | -42.57% |
Current DrawdownCurrent decline from peak | -41.04% | -1.58% | -39.46% |
Average DrawdownAverage peak-to-trough decline | -29.06% | -10.70% | -18.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.51% | 2.14% | +33.37% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Fresenius SE & Co KGaA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Fresenius SE & Co KGaA ADR is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for FSNUY, comparing it with other companies in the Medical Care Facilities industry. Currently, FSNUY has a P/E ratio of 68.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for FSNUY compared to other companies in the Medical Care Facilities industry. FSNUY currently has a PEG ratio of 4.9. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for FSNUY relative to other companies in the Medical Care Facilities industry. Currently, FSNUY has a P/S ratio of 4.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for FSNUY in comparison with other companies in the Medical Care Facilities industry. Currently, FSNUY has a P/B value of 5.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with FSNUY
Add Fresenius SE & Co KGaA ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with FSNUY